BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35695486)

  • 21. Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component.
    Matsumoto S; Nabeshima K; Hamasaki M; Shibuta T; Umemura T
    Med Oncol; 2014 Dec; 31(12):303. PubMed ID: 25358615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris.
    Safari F; Damavandi E; Rostamian AR; Movassaghi S; Imani-Saber Z; Saffari M; Kabuli M; Ghadami M
    Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):326-337. PubMed ID: 34134454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma.
    Santarelli L; Strafella E; Staffolani S; Amati M; Emanuelli M; Sartini D; Pozzi V; Carbonari D; Bracci M; Pignotti E; Mazzanti P; Sabbatini A; Ranaldi R; Gasparini S; Neuzil J; Tomasetti M
    PLoS One; 2011 Apr; 6(4):e18232. PubMed ID: 21483773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
    Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
    Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
    Yamamoto K; Seike M; Takeuchi S; Soeno C; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
    Oncol Rep; 2014 Dec; 32(6):2365-72. PubMed ID: 25231602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.
    Tiedt S; Prestel M; Malik R; Schieferdecker N; Duering M; Kautzky V; Stoycheva I; Böck J; Northoff BH; Klein M; Dorn F; Krohn K; Teupser D; Liesz A; Plesnila N; Holdt LM; Dichgans M
    Circ Res; 2017 Sep; 121(8):970-980. PubMed ID: 28724745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating miR-29c-3p is downregulated in patients with acromegaly.
    Korkmaz H; Hekimler Öztürk K; Torus B
    Turk J Med Sci; 2021 Aug; 51(4):2081-2086. PubMed ID: 34013701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
    Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma.
    Oliveto S; Alfieri R; Miluzio A; Scagliola A; Secli RS; Gasparini P; Grosso S; Cascione L; Mutti L; Biffo S
    Cancer Res; 2018 Oct; 78(20):5741-5753. PubMed ID: 30072395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
    Sato H; Soh J; Aoe K; Fujimoto N; Tanaka S; Namba K; Torigoe H; Shien K; Yamamoto H; Tomida S; Tao H; Okabe K; Kishimoto T; Toyooka S
    Int J Oncol; 2019 Jun; 54(6):2139-2148. PubMed ID: 30942424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis.
    Mukhopadhyay D; Cocco P; Orrù S; Cherchi R; De Matteis S
    Pulmonology; 2024 Feb; ():. PubMed ID: 38402124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos.
    Di Mauro G; Frontini F; Torreggiani E; Iaquinta MR; Caselli A; Mazziotta C; Esposito V; Mazzoni E; Libener R; Grosso F; Maconi A; Martini F; Bononi I; Tognon M
    Sci Rep; 2023 Apr; 13(1):6501. PubMed ID: 37081052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-1 induces growth arrest and apoptosis in malignant mesothelioma.
    Xu Y; Zheng M; Merritt RE; Shrager JB; Wakelee HA; Kratzke RA; Hoang CD
    Chest; 2013 Nov; 144(5):1632-1643. PubMed ID: 23828229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatic Analysis of Potential Biomarker for hsa-miR-196b-5p in Mesothelioma.
    Sohn EJ
    Genet Test Mol Biomarkers; 2021 Dec; 25(12):772-780. PubMed ID: 34874752
    [No Abstract]   [Full Text] [Related]  

  • 37. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
    Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
    Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma.
    Salman A; Abdel Mageed SS; Fathi D; Elrebehy MA; Abulsoud AI; Elshaer SS; Khidr EG; Al-Noshokaty TM; Khaled R; Rizk NI; Elballal MS; Sayed GA; Abd-Elmawla MA; El Tabaa MM; Mohammed OA; Ashraf A; El-Husseiny AA; Midan HM; El-Dakroury WA; Abdel-Reheim MA; Doghish AS
    Pathol Res Pract; 2023 Dec; 252():154947. PubMed ID: 37977032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
    Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
    J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma.
    Truini A; Coco S; Genova C; Mora M; Dal Bello MG; Vanni I; Alama A; Rijavec E; Barletta G; Biello F; Maggioni C; Grossi F
    Microrna; 2016; 5(1):12-18. PubMed ID: 26817512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.